Xinlong Holdings: Shareholder Hainan Zhuhua Plans to Reduce Holdings of No More Than 16.15 Million Shares

Radar Finance | Written by Feng Xiuyu | Edited by Li Yihui

On March 19, Xinlong Holdings (stock abbreviation: Xinlong Holdings) announced that it recently received a notice from its shareholder, Hainan Zhuhua Technology Industry and Trade Co., Ltd., which plans to reduce its holdings by no more than 16,150,000 shares of the company, accounting for 3% of the total share capital, between April 13, 2026, and July 12, 2026.

The purpose of this reduction is to meet the company’s development needs. The reduction will be carried out through two methods: centralized bidding transactions and block trades. Within any consecutive 90 calendar days, the proportion of shares reduced via centralized bidding will not exceed 1% of the total share capital, while the proportion via block trades will not exceed 2%.

It is noteworthy that this reduction is not expected to affect the company’s control rights or have an adverse impact on the company’s governance structure and ongoing operational capabilities.

According to Tianyancha data, Xinlong Holdings was established on July 16, 1993, with a registered capital of 538.395 million RMB. The legal representative is Yu Chunshan, and the registered address is in Laocheng Industrial Development Zone, Chengmai County. Its main businesses include non-woven new materials, pharmaceutical health and consumer products, and investment and trade.

Currently, the company’s chairman is Yu Chunshan, the secretary is Zhou Jufeng, with 536 employees. The actual controllers are Wang Linjiang and Li Guoxiang.

The company has stakes in 19 subsidiaries, including Hainan Coulomb Battery Swap Network Technology Co., Ltd., Hainan Xinlong Coulomb Battery Swap Network Technology Co., Ltd., Hainan Xinlong Private Equity Fund Management Co., Ltd., Hainan Xinlong Nonwoven Co., Ltd., and Hainan Xinlong Medical & Health Co., Ltd.

In terms of performance, the company’s operating income for 2022, 2023, and 2024 was 837 million RMB, 591 million RMB, and 523 million RMB, respectively, with year-on-year changes of -17.62%, -29.42%, and -11.53%. The net profit attributable to shareholders was -120 million RMB, -28.43 million RMB, and -16.61 million RMB, with year-on-year growth rates of -1319.09%, 76.40%, and 41.56%. During the same period, the company’s asset-liability ratio was 26.78%, 20.54%, and 15.44%.

Regarding risks, Tianyancha data shows the company has 335 internal Tianyan risks, 97 surrounding risks, 51 historical risks, and 280 warning alert risks.